64B5-14.008: Requirements for General Anesthesia or Deep Sedation
PURPOSE AND EFFECT: The Board proposes the rule amendment to delete unnecessary language and to add new language to clarify the requirements for general anesthesia or deep sedation.
SUMMARY: The rule amendment will delete unnecessary language and to add new language to clarify the requirements for general anesthesia or deep sedation.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared. The Board determined that small businesses would not be affected by this rule.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
RULEMAKING AUTHORITY: 466.004, 466.017 FS.
LAW IMPLEMENTED: 466.017 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Sue Foster, Executive Director, Board of Dentistry/MQA, 4052 Bald Cypress Way, Bin #C08, Tallahassee, Florida 32399-3258
THE FULL TEXT OF THE PROPOSED RULE IS:
64B5-14.008 Requirements for General Anesthesia or Deep Sedation.
General Anesthesia Permit applicants and permit holders shall comply with the following requirements at each location where anesthesia procedures are performed. The requirements shall be met and equipment permanently maintained and available at each location.
(1) through (2) No change.
(3) The following equipment must be readily available to the operatory and recovery room and maintained in good working order:
(a) through (c) No change.
(d) Cardioscope – electrocardiograph (EKG) machine, and pulse oximeter, and end tidal carbon dioxide to provide continuous monitoring of heart rhythm and rate, of oxygen saturation of the blood, and ventilation. This equipment shall be used for each procedure; and
(e) Defibrillator equipment appropriate for the patient population being treated; and.
(f) Thermometer.
(4) No change.
(5) The following drugs or type of drugs with a current shelf life must be maintained and easily accessible from the operatory and recovery room:
(a) through (p) No change.
(q) Adenosine Sodium bicarbonate; and
(r) No change.
(6) through (7) No change.
Rulemaking Specific Authority 466.004, 466.017 FS. Law Implemented 466.017 FS. History–New 10-24-88, Amended 11-16-89, Formerly 21G-14.008, Amended 12-20-93, Formerly 61F5-14.008, Amended 8-8-96, Formerly 59Q-14.008, Amended 5-31-00, 6-23-04, 9-14-05, 3-23-06,________.